Insider Stock Trading History of Shannon Colin


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Shannon Colin since year 2005. The trader's CIK number is 1285101. At the time of this reporting, Shannon Colin is the President & CEO of Pra Health Sciences, Inc. . (stock ticker symbol PRAH). See this page for all insider trading activities at Pra Health Sciences, Inc. .

Note that in the past SHANNON COLIN also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Shannon Colin since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2017-08-14 PRAH Pra Health Sciences, Inc. Sale 400,000 74.85 29,939,999
2017-08-08 PRAH Pra Health Sciences, Inc. Option Ex 400,000 7.33 2,934,000
2017-03-28 PRAH Pra Health Sciences, Inc. Option Ex 50,000 2.94 147,000
2017-03-28 PRAH Pra Health Sciences, Inc. Sale 50,000 64.00 3,200,000
2017-02-21 PRAH Pra Health Sciences, Inc. Option Ex 2,747 2.94 8,076
2017-02-23 PRAH Pra Health Sciences, Inc. Sale 97,253 61.50 5,981,059
2017-02-23 PRAH Pra Health Sciences, Inc. Option Ex 97,253 2.94 285,923
2017-02-21 PRAH Pra Health Sciences, Inc. Sale 2,747 61.50 168,940
2016-08-18 PRAH Pra Health Sciences, Inc. Option Ex 120,000 2.94 352,800
2016-08-18 PRAH Pra Health Sciences, Inc. Sale 10,822 51.76 560,146
2016-08-19 PRAH Pra Health Sciences, Inc. Sale 19,694 51.40 1,012,271
2016-08-22 PRAH Pra Health Sciences, Inc. Sale 82,617 51.58 4,261,384
2016-03-08 PRAH Pra Health Sciences, Inc. Sale 77,019 42.26 3,254,822
2016-03-02 PRAH Pra Health Sciences, Inc. Option Ex 82,382 2.94 242,203
2007-05-04 PPDI Pharmaceutical Product Development Inc Sale 9,667 35.15 339,746
2007-05-04 PPDI Pharmaceutical Product Development Inc Option Ex 9,667 15.43 149,161
2007-02-09 PPDI Pharmaceutical Product Development Inc Sale 32,500 34.15 1,109,712
2007-02-09 PPDI Pharmaceutical Product Development Inc Option Ex 32,500 21.19 688,675
2006-10-20 PPDI Pharmaceutical Product Development Inc Sale 71,167 35.40 2,519,311
2006-10-20 PPDI Pharmaceutical Product Development Inc Option Ex 71,167 17.00 1,209,625

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Shannon Colin (President & CEO of Pra Health Sciences, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.